Literature DB >> 6131739

Immunohistochemical and electron microscopic assessment of childhood rhabdomyosarcoma. Increased frequency of diagnosis over routine histologic methods.

H J Kahn, H Yeger, O Kassim, A O Jorgensen, D H MacLennan, R Baumal, C R Smith, M J Phillips.   

Abstract

Histologic examination was carried out in 65 cases of childhood rhabdomyosarcoma (RMS), 53 embryonal, and 12 alveolar. Cross-striations were seen on light microscopy in 12 (23%) embryonal and 4 (33%) alveolar tumors. The capacity of immunohistochemical staining (PAP technique) to increase diagnostic accuracy was assessed, using antibodies against myoglobin, the MM isoenzyme of creatine kinase, desmin, calcium magnesium-dependent ATPase of sarcoplasmic reticulum and calsequestrin. Myoglobin was detected in 16 (30%) embryonal and eight (67%) alveolar RMS, higher numbers than obtained by viewing cross-striations on light microscopy. The creatine kinase antibody was slightly better than the antibody to myoglobin and 15 of 25 (60%) embryonal RMS were positive when both specificities were used. The remaining three antibodies were less useful. Of 13 (two alveolar and 11 embryonal) RMS studied by electron microscopy, four showed cross-striations, contained late myoblasts, and were positive for myoglobin. Three additional cases showed only late myoblasts and one of these was positive for myoglobin. Thus, 16 of 25 (64%) of the embryonal and seven of nine (78%) of the alveolar RMS showed either positive immunostaining or ultrastructural features of RMS. This study indicates that a combination of immunohistochemical staining, using antimyoglobin and anticreatine kinase (MM isoenzyme) antibodies, and electron microscopy are useful markers in the diagnosis of childhood RMS.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6131739     DOI: 10.1002/1097-0142(19830515)51:10<1897::aid-cncr2820511023>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  The changing face of hepatic resection.

Authors:  S Iwatsuki; D G Sheahan; T E Starzl
Journal:  Curr Probl Surg       Date:  1989-05       Impact factor: 1.909

2.  Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins.

Authors:  R A Schmidt; R Cone; J E Haas; A M Gown
Journal:  Am J Pathol       Date:  1988-04       Impact factor: 4.307

3.  The value of immunohistochemistry in increasing diagnostic precision of undifferentiated tumours by the surgical pathologist.

Authors:  R Baumal; H J Kahn; D Bailey; M J Phillips; W Hanna
Journal:  Histochem J       Date:  1984-10

4.  An investigation of beta enolase as a histological marker of rhabdomyosarcoma.

Authors:  J A Royds; S Variend; W R Timperley; C B Taylor
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

5.  Soft tissue tumors of the anorectum: rare, complex and misunderstood.

Authors:  Mohammed O Nassif; Nora H Trabulsi; Kelli M Bullard Dunn; Ayoub Nahal; Ari-Nareg Meguerditchian
Journal:  J Gastrointest Oncol       Date:  2013-03

6.  Calcium pump expression in human bone and soft tissue tumours.

Authors:  M Kuroda; H Horiuchi; T Oka; T Ishida; A Ono; M Kawakita; R Machinami
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

Review 7.  Myogenin and MyoD1 expression in paediatric rhabdomyosarcomas.

Authors:  N J Sebire; M Malone
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

8.  Comparison of beta enolase and myoglobin as histological markers of rhabdomyosarcoma.

Authors:  J A Royds; S Variend; W R Timperley; C B Taylor
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

9.  Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy.

Authors:  Lu Yu; Shou Jing Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Desmin is a specific marker for rhabdomyosarcomas of human and rat origin.

Authors:  M Altmannsberger; K Weber; R Droste; M Osborn
Journal:  Am J Pathol       Date:  1985-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.